Detalhe da pesquisa
1.
Limited Flavivirus Cross-Reactive Antibody Responses Elicited by a Zika Virus Deoxyribonucleic Acid Vaccine Candidate in Humans.
J Infect Dis
; 224(9): 1550-1555, 2021 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33961055
2.
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials.
Lancet
; 391(10120): 552-562, 2018 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217376
3.
Zika virus spreads through infection of lymph node-resident macrophages.
Cell Rep
; 42(2): 112126, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795561
4.
Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity.
Cell Host Microbe
; 29(11): 1634-1648.e5, 2021 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34610295
5.
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates.
NPJ Vaccines
; 6(1): 50, 2021 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33837212
6.
Characterization of a Species E Adenovirus Vector as a Zika virus vaccine.
Sci Rep
; 10(1): 3613, 2020 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107394
7.
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates.
bioRxiv
; 2020 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33398289
8.
Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality.
Sci Transl Med
; 12(547)2020 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32522807
9.
Development of a potent Zika virus vaccine using self-amplifying messenger RNA.
Sci Adv
; 6(32): eaba5068, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32821824
10.
Inhibitors of the Histone Methyltransferases EZH2/1 Induce a Potent Antiviral State and Suppress Infection by Diverse Viral Pathogens.
mBio
; 8(4)2017 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28811345
11.
Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates.
NPJ Vaccines
; 6(1): 136, 2021 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34743171
12.
Rapid development of a DNA vaccine for Zika virus.
Science
; 354(6309): 237-240, 2016 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27708058
13.
Bone mineral density changes following discontinuation of ronacaleret treatment: off-treatment extension of a randomized, dose-finding phase II trial.
Bone
; 67: 104-8, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24794093
14.
Ronacaleret, a calcium-sensing receptor antagonist, increases trabecular but not cortical bone in postmenopausal women.
J Bone Miner Res
; 27(2): 255-62, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22052452
15.
The effects of ronacaleret, a calcium-sensing receptor antagonist, on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mineral density.
J Clin Endocrinol Metab
; 96(8): 2441-9, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21593114
16.
Ronacaleret, a calcium-sensing receptor antagonist, has no significant effect on radial fracture healing time: results of a randomized, double-blinded, placebo-controlled Phase II clinical trial.
Bone
; 49(4): 845-52, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21742071
17.
Abacavir once or twice daily combined with once-daily lamivudine and efavirenz for the treatment of antiretroviral-naive HIV-infected adults: results of the Ziagen Once Daily in Antiretroviral Combination Study.
J Acquir Immune Defic Syndr
; 38(4): 417-25, 2005 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15764958